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Crosslinked CRPCyclic AMP receptor protein (CRP), the global transcription regulator in prokaryotes, is active only as
a cAMP–CRP complex. Binding of cAMP changes the conformation of CRP, transforming it from a
transcriptionally ‘inactive’ to an ‘active’ molecule. These conformers are also characterized by
distinct biochemical properties including the ability to form an S–S crosslink between the C178
residues of its two monomeric subunits. We studied a CRP variant (CRPcl), in which the subunits
are crosslinked. We demonstrate that CRPcl can activate transcription even in the absence of cAMP.
Implications of these results for the crystallographically-determined structure of cAMP–CRP are
discussed.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The cyclic AMP receptor protein (CRP, also known as CAP) of
Escherichia coli is a transcription factor that regulates the expres-
sion of more than 100 genes in the bacterium [1–5]. It is a homodi-
mer of 209-residue subunits, comprising the C-terminal DNA
binding domain (DBD, residues 139–209) and the N-terminal
dimerisation domain that binds cAMP (CBD, residues 1–134), with
a short hinge region (residues 135–138) connecting the domains.
CRP is functionally active only when complexed with cAMP, the
binding of which brings about an allosteric change in the protein,
causing it to bind to speciﬁc sites on DNA and activate (or repress)
a number of genes. Changes in several biochemical and physico-
chemical properties distinguish cAMP bound CRP from the unli-
ganded protein. Binding of cAMP (a) makes CRP sensitive to
proteases, (b) reduces the accessibility of its sole accessible cys-
teine residue (C178) and (c) enables the crosslinking of the two
subunits of the protein by an S–S bond at the C178 residues, apart
from other changes in conformation probed by ANS ﬂuorescence,
small angle X-ray scattering or Raman spectroscopy [1].
The ﬁrst three dimensional structures of E. coli cAMP–CRP
appeared in 1981 [6]. Since then, several structures have appeared
for the ligand-bound protein in various forms: alone, as a complexwith DNA or with DNA and a fragment of RNA polymerase [7–11].
However, the molecular details of the conformational changes that
occur in CRP upon cAMP binding became clear only when the
structure of apo-CRP (CRP without cAMP) was obtained by X-ray
crystallography [12] and NMR [13] in 2009. In both the structures
it was observed that binding of cAMP to CBD induces an allosteric
conformational change in DBD mainly through structural changes
in the C-helix of CBD. However, there were certain differences in
the structural change between apo-CRP and cAMP–CRP, as probed
by X-ray crystallography or NMR. In the NMR structure that repre-
sents the conformation of apo-CRP in the solution state, the C-heli-
ces in apo-CRP are 11 residues shorter than in the ligand-bound
structure, while in the X-ray structure, the C-helices are shorter
by 6 residues in apo-CRP. In addition, the F-helices (the recognition
helices of the HTH motif of CRP) are buried in the apo-CRP crystal
structure, while the D-helices are shorter by 4 residues. This struc-
ture also suggests that upon cAMP binding, the DBD domain reori-
ents itself as one rigid body and rotates over the hinge for proper
repositioning of the F helices, making them ﬁt in the DNA major
grooves at the cognate binding site. However, these changes in
the DBD were not clearly observed in the NMR structure [13]. In
fact, the differences in the positioning and conformations of the
different structural elements within the DBD in apo-CRP and
cAMP–CRP suggests a conformational ﬂexibility of the DBD. This
is further reﬂected in the distance between two Cys-178 residues
that lie at the loop connecting the D and E helices in the DBD.
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is almost 8 Å shorter compared to that in the crystallographic
structure. These results are in general agreement with earlier spec-
ulations on the cAMP-induced conformational changes in CRP,
obtained from biochemical experiments using mutant proteins
[14–16], as well as from molecular dynamics studies [17,18].
It has also been proposed that the level of cAMP rather than its
mere presence or absence plays an important role in different bio-
physical and biochemical properties of CRP [19,20]. Two different
conformers of CRP exist at lower and at higher concentrations of
cAMP, with only the low-cAMP conformer being able to activate
transcription [20]. Among other cAMP-dependent structural prop-
erties, CRP undergoes DTNB-induced intersubunit crosslinking of
C178 residues, only at low cAMP [19,20]. It is possible that upon
such crosslinking, the CRP conformation gets locked in the ‘active
state’, formed at low cAMP. If this is true, the crosslinked form of
CRP would represent a conformation in which the hinge movement
is restricted and the molecule is frozen in the active state. There-
fore, this conformer of CRP should be able to exhibit properties
of the molecule that are characteristic of the cAMP–CRP complex,
even in the absence of cAMP. In this paper, we have examined this
interesting possibility.
2. Materials and methods
2.1. Materials
The expression vector pET28a (Novagen), E. coli strains XL1Blue
and BL21 (DE3) were used for cloning and puriﬁcation of CRP. The
plasmid pSA509 containing E. coli galactose promoter was obtained
from Dr. Sankar Adhya, NCI, NIH, USA. E. coli RNA polymerase was
purchased from Epicenter, USA, as a 100% sigma-saturated holoen-
zyme. Chymotrypsin, 5, 50-dithiobis (2-nitrobenzoic acid) (DTNB),
cAMP, IPTG, dithiothreitol (DTT) and NTPs (Sigma), [a-32P] UTP
(BRIT, India), and Ni–NTA agarose (Qiagen), were purchased from
the indicated sources. All other enzymes were from Promega, USA.
2.2. Cloning, expression, and puriﬁcation of CRP from E. coli
Chromosomal DNA was isolated from E. coli (XL1 Blue) by the
bacterial DNA isolation protocol [21]. From the puriﬁed chromo-
somal DNA, the crp gene was PCR-ampliﬁed using the primers
PFCRP (50-CGAAACATATGGTGCTTGGCAAACCGCA-30) and PRCRP
(50-GCGTTGGATCCAATTTAACGAGTGCCGT-30). The PCR product
was digested with NdeI and BamHI and ligated into the correspond-
ing sites of the expression vector pET28a. The resulting plasmid
pABS01 was used to transform the BL21 (DE3) strain. Following
induction at 37 C for 3 h with 0.3 mM IPTG, the expressed protein
was puriﬁed through a Ni–NTA agarose column (pre-equilibrated
with buffer A: 20 mM sodium phosphate (pH 7), 500 mM NaCl,
10% glycerol and 0.5 mM DTT). Elution was done by the addition
of buffer A plus 250 mM imidazole. The protein obtained was
98% pure as estimated from a 13.5% SDS–PAGE followed by Coo-
massie blue staining.
2.3. Intersubunit crosslinking of Cys-178 residues by DTNB and
chymotrypsin digestion
10 lM CRP was treated with 100 lM DTNB in presence of
500 lM of cAMP for 20 min at 22 C, to effect S–S crosslinking
between the Cys-178 residues of the two subunits. Cyclic AMP
and DTNB were removed from the mixture by extensive dialysis
against 50 mM sodium phosphate buffer (pH 7) with three to four
changes. The absorbance spectra of the crosslinked protein sam-
ples were recorded before and after dialysis to ensure that cAMP
was completely removed. Proteolysis of CRP or crosslinked CRP(CRPcl) was carried out in 40 mM Tris–Cl (pH 8.0) with 0.1 M KCl,
10 mMMgCl2 by incubating 20 ll of protein (6–8 lg) with chymo-
trypsin (0.4 lg) at 28 C for 20 min, in the absence or presence of
varying concentrations of cAMP as speciﬁed (20 lM–10 mM). In
each case, the reaction was started with the addition of 2 ll of
0.2 mg/ml chymotrypsin solution and incubated at 28 C for
20 min. Reactions were stopped by adding the gel loading dye fol-
lowed by boiling for 5 min. The digested products were run on a
13.5% SDS–PAGE followed by Coomassie blue staining.
2.4. Preparation of DNA fragments containing different promoter/
operator regions of E.coli
The 145 to +155 region of the E. coli lactose promoter was
PCR-ampliﬁed from E. coli (XL1 Blue) using the primers LacPF
(50-CGCCCATATGGTTGGCCGATTCATTAATGC-30) and LacPR (50-
TTAGGGATCCATTACGCCAGCTGGCGAAAG-30), resulting in a 300-
bp product which was cloned at the NdeI and BamHI sites of
pET28a vector. The cloned plasmid (pABS02) was then transformed
into an E. coli XL1 Blue strain. The lac promoter operator region
used in this work was PCR-ampliﬁed with suitable primers (LacPF
and LacPR). The other promoter region i.e. 197 to +91 of galactose
promoter of E. coli region used in this work was also PCR-ampliﬁed
from plasmid pSA509 with appropriate primers PP287 (50-TGCAT-
GAATTCTTGGCCAACG-30) and PP288 (50-ATTTGCTGCAGTAATTGC-
ACA-30).
2.5. In vitro transcription
Reactions were performed in a 20 ll volume, in transcription
buffer (40 mM Tris–Cl, pH 8.0, 0.1 M K-glutamate, 1 mM DTT,
20 mM MgCl2), using 5 nM of DNA template and 50 nM of RNA
polymerase. After incubation with 100 nM of CRP at 37 C for
20 min, transcription was initiated by the addition of the nucleo-
tide mix (0.1 mM each of ATP, GTP, CTP; 0.01 mM UTP, 5 lCi
[32P] UTP at 3000 Ci/mmol and 1 lg heparin) and terminated after
20 min by adding 10 ll of formamide loading buffer (90% formam-
ide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol).
However in case of CRPcl, 200 nM of protein (including 50% of
the protein that remained in the uncrosslinked form, as detected
from SDS–PAGE) was used and the reaction mixture did not con-
tain any DTT. The protein was freed from cAMP as described ear-
lier. As a negative control, 200 nM of CRPcl was treated with
2 mM DTT and added to the same reaction mixtures. Transcription
experiments were also done with free CRP in the absence and pres-
ence of 20 lM cAMP as additional control. Transcribed RNA was
resolved by electrophoresis on a 10% polyacrylamide-7 M urea
gel. The amounts of transcripts were quantitated with a typhoon
scanner system. To test the effect of varying concentrations of
cAMP on the transcriptional activity of CRP and CRPcl, speciﬁed
amounts of cAMP (16 lM–10 mM) were included in the reaction
mixtures.
2.6. In vitro transcription of CRP and CRPcl for determination of half-
maximal concentrations for transcription activation
The experiments were done as for the in vitro transcription
experiments described above, where all the components of the
reaction mixture were mixed and incubated simultaneously.
Increasing concentrations of proteins were used. In the case of
CRP, a speciﬁed amount of protein (0, 20, 40, 60, 80 or 160 nM)
was incubated with 100 lM of cAMP for 5 min on ice. However
for CRPcl, 0, 40, 80, 120, 160 and 320 nM of total protein (including
50% of the protein that remained in the uncrosslinked form, as
detected from SDS–PAGE) were used, and the reaction mixture
did not contain any DTT or cAMP. Transcribed RNA was resolved
Fig. 2. Limited proteolysis of CRP and CRPcl in the presence or absence of cAMP.
13.5% SDS–PAGE of CRP or CRPcl alone, or treated with 0.4 lg chymotrypsin at 28 C
for 20 min in the absence or presence of cAMP. Lane 1, CRP; lane 2, CRPcl; lane 3,
CRPcl treated with protease; lane 4, CRP treated with protease in the presence of
cAMP; lane 5, CRP treated with protease; lane 6, CRPcl incubated with 20 mM DTT
for 5 min at 28 C prior to protease treatment; lane 7, molecular weight marker.
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amounts of transcripts were quantitated with a typhoon scanner
system, and plotted against protein concentration using SIGMA-
PLOT. Half-maximal concentrations required for transcription acti-
vation were determined from these plots.
3. Results
3.1. Chymotrypsin digestion of the crosslinked CRP (CRPcl)
Upon varying concentrations of cAMP, CRP exhibits a biphasic
behavior [20], and two different conformers of the protein exist
at low and high concentrations of cAMP [19,20]. One such attribute
that exhibits a cAMP-dependent biphasic behavior, is the forma-
tion of crosslink between the –SH groups of the C178 residues of
CRP subunits by DTNB. It has been found that most of the intersub-
unit crosslinking occurs at intermediate levels (100–500 lM) of
cAMP. Therefore in this study, the DTNB reaction was done in the
presence of 500 lM of cAMP to produce crosslinked CRP (data
not shown) and the nucleotide removed subsequently, by dialysis.
The CRPcl used in this experiment did not contain any cAMP, as
ascertained from the absorbance spectrum of CRPcl after dialysis
(Fig. 1). CRP is resistant to cleavage by chymotrypsin in the absence
of cAMP and becomes sensitive only in the presence of cAMP
(20 lM–1mM) [20]. Fig. 2 shows the result of digestion of CRP
and CRPcl at various conditions. CRPcl is readily digested by chymo-
trypsin even in the absence of cAMP, and shows exactly the same
digestion pattern as of (uncrosslinked) CRP in the presence of
0.5 mM cAMP (lanes 3 and 4 of Fig. 2). Moreover, CRPcl treated with
DTT (which would break the S–S crosslink) prior to proteolysis
shows a digestion pattern identical to that of uncrosslinked CRP
in the absence of cAMP (Fig. 2: lanes 6 and 5). These results lead
us to conclude: (i) CRPcl is sensitive to proteolysis by chymotrypsin
even in the absence of cAMP, (ii) The sensitivity of CRPcl to chymo-
trypsin is lost when the crosslinking is removed, and (iii) CRPcl was
indeed free from cAMP contamination.
3.2. Transcriptional activation by CRPcl without cAMP
It has been reported that CRP could activate transcription only
in the presence of low concentrations of cAMP [20]. From the pro-
teolysis experiment described above, it is clear that CRPcl behaves
as the CRP-cAMP complex, when the sensitivity to chymotrypsin is
examined. It was therefore relevant to investigate whether CRPcl
could activate transcription in the absence of cAMP. We tested this
possibility by carrying out in vitro transcription experiments using
CRPcl with both lactose and galactose promoters of E. coli, the
results of which are shown in Fig. 3A and B. It is clear that tran-
scription activation of CRPcl (in the absence of cAMP, lanes 3)
was identical to that by CRP in the presence of cAMP (lanes 4).Fig. 1. Checking the removal of cAMP from CRPcl by UV absorption spectroscopy.
UV absorption spectra of (A) CRP and (B) CRPcl (after dialysis), as compared to the
spectra for cAMP alone (C) or (D) CRPcl (prior to dialysis).As a negative control, in vitro transcription was carried out with
CRPcl treated with DTT that disrupts the crosslink. As expected,
transcription activation was drastically reduced (lanes 2 of
Fig. 3A and B). The transcriptional activities of CRPcl and CRP (in
the presence of 0.1 mM cAMP) were comparable (half-maximal
concentrations for transcription activation = 38 ± 1 nM for CRPcl
and 47 ± 2 nM for cAMP–CRP), as ascertained from in vitro tran-
scription experiments using increasing concentrations of these
proteins (Fig. 4).
3.3. CRPcl is not susceptible to high cAMP concentrations
It has earlier been reported that CRP shows a biphasic change in
various properties including its ability to activate transcription, inFig. 3. Transcription activation of (A) lac and (B) gal promoters by CRPcl without
cAMP. In vitro run-off transcripts in the absence or presence of cAMP are shown.
Lane 1: CRP without cAMP and DTT; lane 2: CRPcl with DTT, but without cAMP; lane
3: CRPcl without cAMP and DTT; lane 4: CRP with 20 lM of cAMP and without DTT;
lane 5: CRP with 20 lM of cAMP and DTT.
Fig. 4. Determination of half-maximal concentrations for transcription activation for CRP and CRPcl. In vitro transcription experiments were carried out with increasing
concentrations of (A) CRP and (B) CRPcl. Lane 1: 0 protein and 0 cAMP, lanes 2–6: 20, 40, 60, 80, 160 nM of CRP and CRPcl. However in case of CRP, lane 2–6 contain 100 lM of
cAMP. In case of CRPcl the reaction mixture did not contain any DTT and cAMP. The protein was freed from cAMP as described earlier. Amounts of transcripts were quantitated
as described, and plotted using SIGMAPLOT. Each point represents data from three independent experiments. The half-maximal concentrations for transcription activation
were determined from these plots.
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centrations, CRP adopts a conformation that is transcriptionally
active and susceptible to proteolytic cleavage, which tends to
reverse at high cAMP [19,20]. Whether CRPcl exhibits such a bipha-
sic behavior was tested by performing chymotrypsin cleavage as
well as in vitro transcription activation by CRP and CRPcl as a func-
tion of cAMP concentration (Fig. 5). Our data show that unlike CRP,
CRPcl remains sensitive to proteolysis (Fig. 5A) and retains its tran-
scription activation property (Fig. 5B) even at high levels of cAMP.
Our results do not exclude the possibility of the binding of cAMP to
the low afﬁnity sites on CRP, but indicate that the apparent confor-
mation of CRPcl remains unaltered at high cAMP concentrations.4. Discussion
From the early days of research on CRP, it has been known that
activation by CRP critically depends upon the presence of cAMP.
When cAMP binds to the N-terminal domain of CRP, it brings about
an allosteric change in the molecule, resulting in a reorientation of
the D and F helices in the C-terminal domain, which then binds to
DNA. Thus the role of cAMP is to facilitate the conformational
change that converts the CRP molecule from an inactive form to
a transcriptionally active form.
When such an ‘active conformer’ of CRP was subjected to cross-
linking by DTNB, forming a covalent S–S bond between the C178
residues in the different subunits, the protein was locked in anFig. 5. Proteolysis (A) and in vitro transcription (B) of CRP and CRPcl in the presence of var
digested with 0.4 lg of chymotrypsin in the presence of indicated amounts of cAMP at 28
panel) or CRPcl (right panel) was preincubated with the indicated amount of cAMP on ice
coli gal promoter) and 50 nM of RNA polymerase, followed by further incubation at 37 C
under Methods. After another 20 min, the reaction was stopped and the products were‘active conformational state’ that no longer required cAMP for acti-
vation of transcription. We have demonstrated that this form of
CRP (CRPcl) was able to activate transcription in vitro, even in the
absence of cAMP.
The above result raises an interesting question regarding the
reported three dimensional structures of CRP. When the distance
between the sulfur atoms of the C178 residues in the two subunits
of CRP is examined, it is found to range between 16 Å and 23 Å
(Table 1). However, in CRPcl this distance cannot exceed 4 Å, since
these atoms are crosslinked by an S–S bond. The differences in the
positions and orientations of the helices and loops in the DBDs of
apo-CRP observed by X-ray diffraction and NMR [12,13] suggests
a conformational ﬂexibility within the DBDs. The fact that CRPcl
represents an active conformation of CRP, in which the distance
between the C178 residues is much shorter compared to those
found in apo-CRP, cAMP–CRP or cAMP–CRP–DNA crystal struc-
tures, may be explained in the light of this conformational ﬂexibil-
ity within the DBD of the CRP dimer. It could thus be possible that
the C178 containing linker region of CRPcl adopts a conformation
that differs from that in cAMP–CRP, but the relative positioning
and orientation of the F helices in the two remain about the same.
In such a case, CRPcl and cAMP–CRP would represent two different
conformers, both of which are transcriptionally active. This possi-
bility is supported by minor differences in the proteolytic digestion
pattern between CRPcl and cAMP–CRP (Fig. 2). On the other hand, if
the DBD of CRP adopts a rigid body structure upon binding of
cAMP, then formation of an S–S bond between the C178 residuesying concentrations of cAMP. (A) 10 lM of CRP (left panel) or CRPcl (right panel) was
C for 20 min. The protease sensitive band is shown by an arrow head. (B) CRP (left
for 5 min, followed by addition to the reaction mixture containing 5 nM template (E.
for 20 min. Transcription was initiated by the addition of the NTP mix, as described
analyzed on a 10% polyacrylamide-7 M urea gel.
Table 1
S–S distance between the C178 residues of the two subunits in different CRP structures.
PDB code Resolution (Å) Nature of the complex S–S distance between C178 residues (Å)
2WC2 (NMR) Apo CRP 16.2
3HIF 3.6 Apo CRP 23.4
1G6N 2.1 cAMP–CRP 21.3
1I5Z 1.9 cAMP–CRP 20.6
2GZW 2.2 cAMP–CRP 22.3
1CGP 3.0 cAMP–CRP–DNA 20.8
2CGP 2.2 cAMP–CRP–DNA 20.9
1RUN 2.7 cAMP–CRP–DNA 21.1
1J59 2.5 cAMP–CRP–DNA 21.0
1O3T 2.8 cAMP–CRP–DNA 21.0
1ZRF 2.1 cAMP–CRP–DNA 20.7
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ther than found in the crystal structures of cAMP–CRP or cAMP–
CRP–DNA. In such a case, these structures may not reﬂect the con-
formationally active form of the molecule, in which the hinge
movement and reorientation of the relevant helices is complete.
Further, we used three bifunctional cysteine reactive crosslinkers
of varying lengths to crosslink the CRP monomers (data not
shown). Our preliminary results indicate that the smallest of these,
1,3-dichloroacetone (DCA), could crosslink the subunits only in the
presence of cAMP, just like DTNB. The other two, viz. 1,8-
bis(maleimido) diethylene glycol (BMPEG-2, distance between
the crosslinking points = 14.7 Å) and 1,11-bis(maleimido) triethyl-
ene glycol (BMPEG-3, distance between the crosslinking
points = 17.8 Å) could form crosslinks both in the absence or pres-
ence of cAMP (data not shown). Most signiﬁcantly, CRP molecules
crosslinked with BMPEG-2 or BMPEG-3 were able to activate tran-
scription only in the presence of cAMP, unlike CRPcl. These results
emphasize that the DBDs of the CRP dimer attain the ﬂexibility to
come within 4 Å for DTNB- or DCA-mediated crosslinking only
upon cAMP binding. The ability of the longer crosslinkers to acti-
vate transcription in the presence of cAMP indicates that neither
the ﬂexibility nor the reduction of the inter-domain distance is
absolutely essential for activation of transcription by CRP. The
results of Fig. 5 suggests that crosslinking of the two subunits pre-
vents CRP from reverting to the cAMP unbound conformation at
high cAMP. As a result, the cAMP-dependent biphasic behavior
observed for CRP is not observed for CRPcl. These observations
underline the role of protein dynamics in transforming CRP to an
active conformer upon cAMP binding [22]. The conformation of
cAMP–CRP as observed in crystals, and of CRPcl may represent
two extremes of a family of structures, all of which are transcrip-
tionally competent.
In the biological context, which of these activating structures is
more relevant? The crystallographically determined activating
structure agrees with the electron microscopy-derived structural
organization in the transcription machinery [23], strongly suggest-
ing that the latter structure represents the functionally active con-
formation. Nevertheless, it is important to note that the crystal
structures of CRP-cAMP-DNA were obtained using half-site-DNA
templates, and the relative orientation of the two half-site DNA
molecules with respect to the CRP dimer were depicted using MOL-
SCRIPT modeling. Though these structures represent detailed inter-
actions between the DNA binding domain of CRP and the CRP
binding sites on DNA, the relative positioning of the DNA binding
domains and the DNA bending of the two half site DNA molecules
in these complexes may marginally differ from the transcription-
ally active CRP conformations. The exact organization of the DNA
binding domain in the CRP-cAMP-DNA complex can only be visu-
alized by obtaining the structure of a CRP-cAMP-DNA complex
using a DNA fragment containing the full binding site of CRP. Crys-
tallization of such a complex has recently been reported [24], but
the solved structure is not yet available.Acknowledgments
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